胞外超氧化物歧化酶(SOD3)單克隆抗體
Monoclonal Antibody to Superoxide Dismutase 3, Extracellular (SOD3)
SOD-3; EC-SOD; Extracellular Superoxide Dismutase Cu-Zn
- 編號MAA117Hu27
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(克隆號)C9
- Ig亞型 IgG2a Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標記物無標記物
- 免疫原 RPA117Hu01-胞外超氧化物歧化酶(SOD3)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 639 ¥ 1491 ¥ 2130 ¥ 5325 ¥ 21300
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P; Sample: Porcine Spleen Tissue Primary Ab: 40μg/ml Mouse Anti-Human SOD3 Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對SOD3的小鼠單克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別SOD3。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| APA117Hu01 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA117Hu62 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA117Hu03 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA117Hu04 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA117Hu01 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPA117Hu61 | 胞外超氧化物歧化酶(SOD3)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA117Hu02 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA117Hu03 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA117Hu04 | 胞外超氧化物歧化酶(SOD3)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA117Hu61 | 胞外超氧化物歧化酶(SOD3)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAA117Hu01 | 胞外超氧化物歧化酶(SOD3)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA117Hu71 | 胞外超氧化物歧化酶(SOD3)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA117Hu23 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA117Hu24 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | IHC |
| MAA117Hu25 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA117Hu22 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB |
| MAA117Hu21 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA117Hu27 | 胞外超氧化物歧化酶(SOD3)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA117Hu | 胞外超氧化物歧化酶(SOD3)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA117Hu | 胞外超氧化物歧化酶(SOD3)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Current Alzheimer Research | Comparison of Extracellular and Intracellular Blood Compartments Highlights Redox Alterations in Alzheimer's and Mild Cognitive Impairment Patients. [pubmed:27748187] |
| Frontiers in Microbiology | Burn Serum Increases Staphylococcus aureus Biofilm Formation via Oxidative Stress. [pubmed:28702016] |
| Nature?Communications | SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α [Pubmed:29422508] |
| BMC?Neuroscience | Neuroprotective dobutamine treatment upregulates superoxide dismutase 3, anti-oxidant and survival genes and attenuates genes mediating inflammation [Pubmed:29523072] |
| Diabetes-Metabolism?Research?and Reviews | Myeloperoxidase, superoxide dismutase‐3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study [Pubmed:29577557] |
| Advances in Medical Sciences | Selected elements of extracellular matrix of the skin in diabetes and insulin resistance [Pubmed: 31146169] |
| Clinical Kidney Journal | Serum uromodulin is inversely associated with biomarkers of subclinical inflammation in the population-based KORA F4 study [] |
| PLoS One | Association of circulating MR-proADM with all-cause and cardiovascular mortality in the general population: Results from the KORA F4 cohort study [Pubmed:34990470] |
| ORIGINAL RESEARCH PATHOPHYSIOLOGY | EFFECTS OF HIS-PHE-ARG-TRP-PRO-GLY-PRO PEPTIDE ON FREE-RADICAL OXIDATION PROCESSES IN CONDITIONS OF CHRONIC RESTRAINT?… [] |
留言咨詢
